{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T19:18:44Z","timestamp":1722799124911},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Aneurysmal subarachnoid hemorrhage often leads to death and poor clinical outcome. Injury occurring during the first 72 hours is termed \u201cearly brain injury,\u201d with disruption of the nitric oxide pathway playing an important pathophysiologic role in its development. Quantitative electroencephalographic variables, such as \u03b1\/\u03b4 frequency ratio, are surrogate markers of cerebral ischemia. This study assessed the quantitative electroencephalographic response to a cerebral nitric oxide donor (intravenous sodium nitrite) to explore whether this correlates with the eventual development of delayed cerebral ischemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Unblinded pilot study testing response to drug intervention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Neuroscience ICU, John Radcliffe Hospital, Oxford, United Kingdom.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Fourteen World Federation of Neurosurgeons grades 3, 4, and 5 patients (mean age, 52.8 yr [range, 41\u201369 yr]; 11 women).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>IV sodium nitrite (10 \u03bcg\/kg\/min) for 1 hour.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Continuous electroencephalographic recording for 2 hours. The alpha\/delta frequency ratio was measured before and during IV sodium nitrite infusion. Seven of 14 patients developed delayed cerebral ischemia. There was a +30% to +118% (range) increase in the alpha\/delta frequency ratio in patients who did not develop delayed cerebral ischemia (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) but an overall decrease in the alpha\/delta frequency ratio in those patients who did develop delayed cerebral ischemia (range, +11% to \u201331%) (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.006, multivariate analysis accounting for major confounds).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Administration of sodium nitrite after severe subarachnoid hemorrhage differentially influences quantitative electroencephalographic variables depending on the patient\u2019s susceptibility to development of delayed cerebral ischemia. With further validation in a larger sample size, this response may be developed as a tool for risk stratification after aneurysmal subarachnoid hemorrhage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000001950","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T21:41:16Z","timestamp":1469137276000},"page":"e1067-e1073","source":"Crossref","is-referenced-by-count":9,"title":["Electroencephalographic Response to Sodium Nitrite May Predict Delayed Cerebral Ischemia After Severe Subarachnoid Hemorrhage"],"prefix":"10.1097","volume":"44","author":[{"given":"Payashi S.","family":"Garry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyn","family":"Ezra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Herigstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Hayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie W.","family":"Sleigh","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, University of Auckland, Waikato Hospital, Hamilton, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine E.","family":"Warnaby","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle T. S.","family":"Pattinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","article-title":"Subarachnoid haemorrhage.","volume":"369","author":"van Gijn","year":"2007","journal-title":"Lancet"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/01.STR.31.8.1843","article-title":"Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: Incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS).","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bja\/aes264","article-title":"Delayed cerebral ischaemia after subarachnoid haemorrhage: Looking beyond vasospasm.","volume":"109","author":"Rowland","year":"2012","journal-title":"Br J Anaesth"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1990.73.1.0018","article-title":"The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results.","volume":"73","author":"Kassell","year":"1990","journal-title":"J Neurosurg"},{"key":"R5-20230728","first-page":"1017","article-title":"Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage.","volume":"52","author":"Minhas","year":"2003","journal-title":"Neurosurgery"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/jnnp.2006.089748","article-title":"Acute physiological derangement is associated with early radiographic cerebral infarction after subarachnoid haemorrhage.","volume":"77","author":"Naidech","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-7091-1192-5_7","article-title":"Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).","volume":"115","author":"Macdonald","year":"2013","journal-title":"Acta Neurochir Suppl"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12975-013-0257-2","article-title":"Early brain injury, an evolving frontier in subarachnoid hemorrhage research.","volume":"4","author":"Fujii","year":"2013","journal-title":"Transl Stroke Res"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3174\/ajnr.A3420","article-title":"Metabolic changes in patients with aneurysmal subarachnoid hemorrhage apart from perfusion deficits: Neuronal mitochondrial injury?","volume":"34","author":"Wagner","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/ane.12258","article-title":"Bedside diagnosis of mitochondrial dysfunction in aneurysmal subarachnoid hemorrhage.","volume":"130","author":"Jacobsen","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2014.10.017","article-title":"The role of the nitric oxide pathway in brain injury and its treatment\u2013from bench to bedside.","volume":"263","author":"Garry","year":"2015","journal-title":"Exp Neurol"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1073\/pnas.0801336105","article-title":"Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury.","volume":"105","author":"Hendgen-Cotta","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"20474","DOI":"10.1074\/jbc.M001077200","article-title":"Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release.","volume":"275","author":"Brookes","year":"2000","journal-title":"J Biol Chem"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10548-012-0265-7","article-title":"Coupling between resting cerebral perfusion and EEG.","volume":"26","author":"O\u2019Gorman","year":"2013","journal-title":"Brain Topogr"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.clinph.2004.06.017","article-title":"Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage.","volume":"115","author":"Claassen","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0013-4694(97)00071-0","article-title":"Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring.","volume":"103","author":"Vespa","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0013-4694(91)90094-K","article-title":"Quantitative EEG monitoring for patients with subarachnoid hemorrhage.","volume":"78","author":"Labar","year":"1991","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.clinph.2014.10.215","article-title":"Early prediction of delayed cerebral ischemia in subarachnoid hemorrhage based on quantitative EEG: A prospective study in adults.","volume":"126","author":"Gollwitzer","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/cc11230","article-title":"Quantitative EEG for the detection of brain ischemia.","volume":"16","author":"Foreman","year":"2012","journal-title":"Crit Care"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group.","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00415-008-0796-8","article-title":"What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?","volume":"255","author":"Weisscher","year":"2008","journal-title":"J Neurol"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysis.","volume":"134","author":"Delorme","year":"2004","journal-title":"J Neurosci Methods"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"156869","DOI":"10.1155\/2011\/156869","article-title":"FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data.","volume":"2011","author":"Oostenveld","year":"2011","journal-title":"Comput Intell Neurosci"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.293.12.1477","article-title":"Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.","volume":"293","author":"Pluta","year":"2005","journal-title":"JAMA"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/STROKEAHA.111.638403","article-title":"Predicting the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.","volume":"43","author":"Crobeddu","year":"2012","journal-title":"Stroke"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrneurol.2013.11","article-title":"Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage.","volume":"9","author":"Budohoski","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease.","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12028-010-9495-2","article-title":"Using continuous electroencephalography in the management of delayed cerebral ischemia following subarachnoid hemorrhage.","volume":"14","author":"Rathakrishnan","year":"2011","journal-title":"Neurocrit Care"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12028-014-0068-7","article-title":"Continuous EEG monitoring in aneurysmal subarachnoid hemorrhage: A systematic review.","volume":"22","author":"Kondziella","year":"2015","journal-title":"Neurocrit Care"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201611000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T08:34:50Z","timestamp":1690533290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201611000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000001950","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}